Estimated reading time: seven (7) minutes
US/Silver Spring: WeFun Inc., a Brooklyn, New York establishment, recalls an estimated 300 Boxes of WeFun Nutritional Supplement Capsules from the American marketplace due to reported undeclared Sildenafil, an FDA approved drug for the treatment of Male Erectile Dysfunction (“ED”), Benign Prostatic Hyperplasia (“BPH”) and certain other medical conditions and in a class of drugs called Phosphodiesterase (“PDE-5”) Inhibitors with consequential risks of dangerous low blood pressure, injury and possible life-changing complications, all serious health and safety hazards.
FDA: https://rb.gy/qbkbz
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Dietary Supplement products are subject to this recall:
Filed under: Dietary Supplements, Drugs, Labeling or regulatory issues, Medical / Veterinary, Sildenafil, US FDA | Tagged: Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia ("BPH"), Dietary Supplements, Male Erectile Dysfunction ("ED"), Recalls Direct RIN: 17541-2023, undeclared Sildenafil hazard, US FDA, US Food and Drug Administration, WeFun Inc., WeFun Nutritional Supplement Capsules, WeFun Supplement Capsules | Leave a comment »